BRIVIACT Trademark

Trademark Overview

On Monday, July 27, 2015, a trademark application was filed for BRIVIACT with the United States Patent and Trademark Office. The USPTO has given the BRIVIACT trademark a serial number of 79172779. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Monday, April 1, 2024. This trademark is owned by UCB Biopharma SPRL. The BRIVIACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and substances for the treatment of central nervous system diseases [ and for the treatment of immune system diseases ]
briviact

General Information

Serial Number79172779
Word MarkBRIVIACT
Filing DateMonday, July 27, 2015
Status709 - CANCELLED - SECTION 71
Status DateMonday, April 1, 2024
Registration Number5000660
Registration DateTuesday, July 19, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements

Description of MarkThe mark consists of the word "BRIVIACT" in burgundy stylized form, to the right of a concentric circle design comprised of a burgundy shaded circle inside a wide white circle, enclosed within a shaded green quadrilateral with rounded corners, above a shaded gray oval, all inside a white rectangle.
Goods and ServicesPharmaceutical products and substances for the treatment of central nervous system diseases [ and for the treatment of immune system diseases ]
Indication of Colors claimedThe color(s) BURGUNDY, GREEN, GRAY and WHITE is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateMonday, April 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB Biopharma SRL
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressBRUXELLES B-1070
BE
Party NameUCB Biopharma SPRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB Biopharma SPRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB Biopharma SPRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF CANCELLATION SEC. 71 E-MAILED
Monday, April 1, 2024CANCELLED SECTION 71
Friday, October 13, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sunday, October 8, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, February 8, 2023POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Wednesday, February 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 29, 2022TEAS SECTION 71 & 15 RECEIVED
Monday, July 19, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, November 10, 2020CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 2, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 17, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 17, 2016FINAL DISPOSITION PROCESSED
Wednesday, October 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 19, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 28, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, March 22, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 22, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, March 22, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2016NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 31, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 31, 2016NON-FINAL ACTION E-MAILED
Sunday, January 31, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 29, 2015ASSIGNED TO LIE
Wednesday, December 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 8, 2015REFUSAL PROCESSED BY IB
Wednesday, October 21, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 21, 2015REFUSAL PROCESSED BY MPU
Tuesday, October 20, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 19, 2015NON-FINAL ACTION WRITTEN
Sunday, October 18, 2015ASSIGNED TO EXAMINER
Friday, October 2, 2015APPLICATION FILING RECEIPT MAILED
Monday, September 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 25, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 24, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

briviact system treatment diseases immune nervous central products substances pharmaceutical